• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿石症、抑制剂与促进剂。

Urolithiasis, inhibitors and promoters.

作者信息

Grases F, Conte A

机构信息

Dpt. Chemistry, University Illes Balears, Palma de Mallorca, Spain.

出版信息

Urol Res. 1992;20(1):86-8. doi: 10.1007/BF00294344.

DOI:10.1007/BF00294344
PMID:1736493
Abstract

The aim of this work is to evaluate the role and importance of inhibitors and promoters in urolithiasis. Carrying in mind theoretical considerations, we conclude that in urolithogenic processes, inhibitors and promoters could only play a decisive role in the "idiopathic" oxalocalcic urolithiasis. We classify the "idiopathic" oxalocalcic stone-formers into three main groups, considering inhibitory and promoting factors. It is shown that such classification is in good agreement with the clinical results observed in a group of 88 "idiopathic" oxalocalcic stone-formers.

摘要

这项工作的目的是评估抑制剂和促进剂在尿路结石形成中的作用及重要性。基于理论考量,我们得出结论:在尿路结石形成过程中,抑制剂和促进剂仅在“特发性”草酸钙结石形成中起决定性作用。考虑到抑制和促进因素,我们将“特发性”草酸钙结石形成者分为三个主要组。结果表明,这种分类与在一组88名“特发性”草酸钙结石形成者中观察到的临床结果高度吻合。

相似文献

1
Urolithiasis, inhibitors and promoters.尿石症、抑制剂与促进剂。
Urol Res. 1992;20(1):86-8. doi: 10.1007/BF00294344.
2
Inhibitors of calcium oxalate crystallization and urolithiasis.
Urol Int. 1992;48(4):409-14. doi: 10.1159/000282365.
3
Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.正常人及特发性草酸钙结石患者中过饱和度与草酸钙结晶的关系。
Kidney Int. 1999 Mar;55(3):1041-50. doi: 10.1046/j.1523-1755.1999.0550031041.x.
4
[Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].[含钙尿路结石中某些结晶促进剂和抑制剂的24小时排泄量及草酸钙尿液饱和度的评估]
Pol Arch Med Wewn. 1994 Oct;92(4):289-98.
5
Chronopharmacological studies on potassium citrate treatment of oxalocalcic urolithiasis.
Int Urol Nephrol. 1997;29(3):263-73. doi: 10.1007/BF02550921.
6
The role of overweight and obesity in calcium oxalate stone formation.超重和肥胖在草酸钙结石形成中的作用。
Obes Res. 2004 Jan;12(1):106-13. doi: 10.1038/oby.2004.14.
7
Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.特发性复发性草酸钙尿石症男性患者餐后尿中草酸钙成核与磷酸钙成核及结石形成强度有关吗?有助于深入了解尿游离柠檬酸盐和蛋白质可能作用的研究。
Clin Chem Lab Med. 2004 Mar;42(3):283-93. doi: 10.1515/CCLM.2004.052.
8
Simple test to evaluate the risk of urinary calcium stone formation.评估尿钙结石形成风险的简易测试。
Clin Chim Acta. 1997 Jul 4;263(1):43-55. doi: 10.1016/s0009-8981(97)06554-6.
9
Measurement of the risk of calcium oxalate crystallization in urine.尿液中草酸钙结晶风险的测量。
Urol Res. 1985;13(6):297-300. doi: 10.1007/BF00262660.
10
Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.尿大分子对特发性结石形成者和健康对照者草酸钙成核的影响。
Clin Chim Acta. 1995 Jul 31;239(1):1-11. doi: 10.1016/0009-8981(95)06092-r.

引用本文的文献

1
Mechanisms of Stone Formation.结石形成的机制。
Clin Rev Bone Miner Metab. 2011 Dec;9(3-4):187-197. doi: 10.1007/s12018-011-9104-8.
2
Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers.对正常受试者和草酸钙结石形成者经标准化体积调整的12小时夜间尿液中的尿液成分及钙盐结晶特性进行评估。
Urol Res. 1997;25(5):365-72. doi: 10.1007/BF01294667.
3
In vitro crystallisation systems for the study of urinary stone formation.

本文引用的文献

1
Inhibitory effect of pyrophosphate, citrate, magnesium and chondroitin sulphate in calcium oxalate urolithiasis.焦磷酸盐、柠檬酸盐、镁和硫酸软骨素在草酸钙尿路结石中的抑制作用。
Br J Urol. 1989 Sep;64(3):235-7. doi: 10.1111/j.1464-410x.1989.tb06004.x.
2
The relation between orthophosphate and pyrophosphate in normal subjects and in patients with urolithiasis.
Urol Res. 1989;17(3):173-5. doi: 10.1007/BF00256246.
3
Urolithiasis inhibitors and calculus nucleation.尿路结石抑制剂与结石成核
用于研究尿路结石形成的体外结晶系统。
World J Urol. 1997;15(4):244-51. doi: 10.1007/BF01367662.
4
Calcium phosphate: an important crystal phase in patients with recurrent calcium stone formation?磷酸钙:复发性钙结石形成患者的一种重要晶相?
Urol Res. 1993 May;21(3):175-80. doi: 10.1007/BF00590033.
5
Epidemiology of urinary stone disease in the Balearic Islands Community.巴利阿里群岛自治区尿路结石病的流行病学
Int Urol Nephrol. 1994;26(2):145-50. doi: 10.1007/BF02768277.
6
Urolithiasis and phytotherapy.尿石症与植物疗法
Int Urol Nephrol. 1994;26(5):507-11. doi: 10.1007/BF02767650.
Urol Res. 1989;17(3):163-6. doi: 10.1007/BF00256244.
4
Uric acid and its relationship with glycosaminoglycans in normal and stone-former subjects.正常人和结石患者体内尿酸及其与糖胺聚糖的关系。
Nephron. 1989;52(2):162-5. doi: 10.1159/000185621.
5
On the relation between citrate and calcium in normal and stone-former subjects.正常人和结石患者体内柠檬酸盐与钙的关系
Int Urol Nephrol. 1990;22(1):7-12. doi: 10.1007/BF02550430.
6
Study of factors affecting calcium oxalate crystalline aggregation.草酸钙晶体聚集影响因素的研究
Br J Urol. 1990 Sep;66(3):240-4. doi: 10.1111/j.1464-410x.1990.tb14919.x.